Showing results (401-410 of 443) with videos related to

Sort By:
Pageof 45
Proceedings of the National Academy of Sciences of the United States of America|March 9, 2013
Therapeutically targeting glypican-3 via a conformation-specific single-domain antibody in hepatocellular carcinomaMingqian Feng, Wei Gao, Ruoqi Wang, et al.
Journal of Translational Medicine|August 5, 2020
32A9, a novel human antibody for designing an immunotoxin and CAR-T cells against glypican-3 in hepatocellular carcinomaXiaoyu Liu, Fang Gao, Longwei Jiang, et al.
Bioconjugate Chemistry|August 22, 2024
Sortase-Mediated Site-Specific Conjugation to Prepare Fluorine-18-Labeled NanobodiesFalguni Basuli, Jianfeng Shi, Eric Lindberg, et al.
Biorxiv : the Preprint Server for Biology|May 7, 2026
Allogeneic CRISPR-Engineered CAR-T Cells Drive Potent Antitumor Activity in Solid TumorsMingyu Huo, Dan Li, Nan Li, et al.
Nature Reviews. Cancer|May 13, 2024
Cancer therapy with antibodiesSuman Paul, Maximilian F Konig, Drew M Pardoll, et al.
Neuro-Oncology|April 12, 2008
Intracerebral infusion of an EGFR-targeted toxin in recurrent malignant brain tumorsJohn H Sampson, Gamal Akabani, Gerald E Archer, et al.
Nanomedicine (London, England)|May 2, 2015
Photoimmunotherapy of hepatocellular carcinoma-targeting Glypican-3 combined with nanosized albumin-bound paclitaxelHirofumi Hanaoka, Takahito Nakajima, Kazuhide Sato, et al.
Pageof 45